#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Erythema multiforme Neuromyelitis optica spectrum disorder Hypophosphatasia Gastric cancer Neonatal asphyxia Barth syndrome Sjogren's syndrome Infertility male X-linked lymphoproliferative syndrome Cardiac sarcoidosis Sickle cell anaemia Familial dilated cardiomyopathy Chordoma Splenic marginal zone lymphoma VEXAS syndrome More trials…

    Learn about Rare Diseases

    Haemophilia – Basic Information Toxic epidermal necrolysis – Life with Disease Adrenocortical carcinoma – Treatment Paraneoplastic neurological syndrome – Treatment Mucopolysaccharidosis I – Treatment Leukoencephalopathy Wiskott-Aldrich syndrome – Diagnostics Ewing’s sarcoma Combined immunodeficiency Rett syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Plerixafor Pramipexole ALFENTANIL HYDROCHLORIDE ALXN1920 Crn04894 Sirolimus Mebufotenin Aficamten Psilocybine Threonine Opevesostat Tosilate Elraglusib Capmatinib Epirubicin Hydrochloride Rbp030.2 Tadalafil Alogliptin Zilovertamab Vedotin Belatacept Levomepromazine Hydrochloride More therapies…

    Learn about Your Condition

    Renal cancer Monkeypox T-cell lymphoma Mantle cell lymphoma stage IV Endocrine ophthalmopathy Craniosynostosis Sickle cell anaemia Neck pain Endometrial cancer stage II Mantle cell lymphoma recurrent Tumour thrombosis Follicular lymphoma stage IV HER2 protein overexpression Kearns-Sayre syndrome Left ventricular dysfunction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Klinikum Idar-Oberstein GmbH

Klinikum Idar-Oberstein GmbH

Drzaakmtcqxuaokkvbdxbvggp 2c Ielzn Iqqrybyymeeprkj 5hnnxq Gjeafct

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    • Obinutuzumab
    • Venetoclax
    Austria Germany Portugal

  • Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Blinatumomab
    • Ponatinib
    • Imatinib
    Germany

  • Study on Reducing Side Effects in Advanced Hodgkin Lymphoma Using Brentuximab Vedotin and Drug Combination for Newly Diagnosed Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Brentuximab Vedotin
    • Procarbazine Hydrochloride
    • Bleomycin Sulfate
    Austria Denmark Germany The Netherlands Norway Sweden

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!